bioRxivImmunologyPreprint
Clonal analysis of SepSecS-specific CD4 T cells reveals a new HLA-DPA1*02:01/HLA-DPB1*01:01-restricted immunodominant epitope in autoimmune hepatitis
Thomas GuinebretièreiD, Alexandra GarciaiD, Chuang DongiD, Laura Bernier, Virginie Huchet, Pierre-Jean GavlovskyiD, Laurine Gil, Sakina Ado, Caroline ChevalieriD, Jean‐Paul Judor, Béatrice ClemenceauiD, Marion Khaldi, Edouard Bardou‐JacquetiD, Laure ElkriefiD, Adrien Lannes, Christine SilvainiD, Matthieu SchneeiD, Florence Tanné, Sara LemoinneiD, Eléonora De MartiniD, Fabienne VavasseuriD, David Axel LaplaudiD, William W. KwokiD, Sophie BrouardiD, Jean‐François MosnieriD, , Amédée RenandiD
Abstract
Autoreactive CD4 T cells, recognizing liver-self-antigens such as SepSecS, are main drivers of the chronic inflammatory response during autoimmune hepatitis (AIH). Previous studies have uncovered immunodominant SepSecS epitopes often associated with HLA-DRB1*03 or HLA-DRB1*04 restriction, two alleles enriched in AIH population. However, HLA restriction of numerous SepSecS epitopes remains incomplete and it is still unclear if immunodominant epitopes could be presented by non-HLA-DR molecules. Here, we investigated epitope recognition of SepSecS-specific TCRs isolated from AIH patients, and their HLA restriction by generating TCR hybridoma cell lines. Seventeen TCRs recognized eight SepSecS epitopes with four distinct HLA restrictions, including a novel HLA-DPA1*02:01/DPB1*01:01-restricted SepSecS epitope. TCR clustering analysis using GLIPH2 algorithm suggested that this epitope is recognized by multiple distinct TCRs in HLA-DPA1*02:01[~]HLA-DPB1*01:01 patients. Our study provides new insights into liver-self-antigen T cell reactivity during AIH, which could offer potential therapeutic strategies by targeting autoreactive CD4 T cells.
- organism: human
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: cell-cell communication
- approach: experimental assay
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis
A. Renaud, I. Cervera-Marzal, … S. Conchon·Journal of HepatologyPeer-reviewed·Dec 1, 2020
- Accumulation of PD-1+ TIGIT+ T cells in the liver after local antigen reactivity and during autoimmune hepatitis
Thomas Guinebretière, Anaïs Cardon, … Amédée Renand·bioRxiv·Aug 29, 2025
- Preclinical model for the study of immune responses specific for a hepatic self-antigen
A. Cardon, J.-P. Judor, … A. Renand·bioRxiv·Jun 22, 2022
- Hepatic CD8+TOX+ T-cells are a hallmark of autoimmune hepatitis
Marc Samuel Sherman, Daniel M Schafer, … Wolfram Goessling·bioRxiv·Jul 9, 2026
- The immune profile of circulating autoreactive CD4 T cells is imprinted through tissue activation during autoimmune liver diseases
Anaïs Cardon, Thomas Guinebretière, … Amédée Renand·Nature CommunicationsPeer-reviewed·Jan 29, 2025
- Advancing Tolerogenic Immunotherapy: A Multi-Epitope Vaccine Design Targeting the CYP2D6 Autoantigen in Autoimmune Hepatitis Through Immuno-Informatics
Harish Babu Kolla, Anuj Kumar, … Channakeshava Sokke Umeshappa·bioRxiv·Apr 17, 2024